Webcast series:
Global regulatory requirements for DDC products

CEO & Founder Gloria has a background in Pharmacy and Chemistry. She has worked for 10 years in the pharmaceutical industry, in both local Mexican companies and American and European multinational companies. After that, she started freelancing in regulatory services until she established Rafconsulting 11 years ago, with a solid team to provide regulatory and pharmacovigilance services. Currently, the team helps national and international companies to successfully launch regulated products in Mexico. They have more than 32 years of experience writing success stories. They have assisted the healthcare industry and other sectors requiring regulatory services with marketing approvals for a broad range of products such as pharmaceuticals, medical devices, food supplements, cosmetics, among others. They are also experts in consulting on borderline products and start-ups, and they provide turnkey services when requested by clients. In some cases, they also coordinate registrations with their agents throughout Latin America.
More information please click here.

Scientific and Regulatory Affairs | Medical Technology | In vitro Diagnostic Medical Devices | Combi Francisco has developed his knowledge in the field of regulatory science for medical devices through dedicated study and experience. He completed his undergraduate studies in Biomedicine, followed by a Master's degree in the Pharmaceutical and Biotechnology Industry, a MedTech Expert postgraduate degree and an Industrial PhD in Biomedicine with special focus on Regulatory Science. Francisco is active member of the Spanish Association of Pharmacists in the Industry (AEFI), where he is involved in the coordination of the drug device combination products working group. His area of expertise includes substance-based medical devices, health products in borderline regulatory categories, software, and drug device combinations.

Deputy General Director "Technical Affairs" 15 years’ experience in different fields comprising RA and IPR in the pharmaceutical area. As a member of SIPSMENA team, Ala’a has been subjected to various other areas in the pharmaceutical industry such as agent selection, legal requirements, market access and others.
More information please click here.

Jack has more than 26 years experience in the Pharma and MedTech sector. He is the founder of Asia Regulatory Professionals Association (ARPA) with more than 7000 members. He is author of "Medical Regulatory Affairs Handbook" (3rd edition). He has a position as adjunct professor/lecturer at the Chinese University of Hong Kong, Hong Kong University, National University of Singapore and Tohoku University Japan. He is CEO of RNAscence (a Biotech start-up spin off from Nanyang Technological University and National Skin Centre Singapore).